These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Prostate Carcinoma-therapeutic considerations in the management of gross lymph node metastases. Green N; Broth E; George FW; Goldstein A; Melbye RW; Morrow J; Onofrio R; Polse S; Skaist L Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):891-7. PubMed ID: 115816 [No Abstract] [Full Text] [Related]
46. Cancer of the prostate: current perspectives. Hilaris BS; Nori D; Batata M Cancer Invest; 1987; 5(5):459-68. PubMed ID: 3322512 [No Abstract] [Full Text] [Related]
47. Cutaneous metastasis in prostatic carcinoma. Pal D; Talwar V; Doval DC; Jalpota YP; Kumar N Indian J Dermatol Venereol Leprol; 2009; 75(3):311-2. PubMed ID: 19439894 [No Abstract] [Full Text] [Related]
48. [Diagnosis, treatment and prognosis of prostatic carcinoma]. Rothkopf M Dtsch Gesundheitsw; 1969 Mar; 24(13):609-13. PubMed ID: 5375970 [No Abstract] [Full Text] [Related]
49. Metastases of prostatic carcinoma to the breast. Salyer WR; Salyer DC J Urol; 1973 Apr; 109(4):671-5. PubMed ID: 4695111 [No Abstract] [Full Text] [Related]
50. Treatment of advanced prostatic carcinoma. Br Med J; 1979 Sep; 2(6193):752-3. PubMed ID: 519177 [No Abstract] [Full Text] [Related]
52. Conservative treatment of early carcinoma of prostate. Comparison of patients less than seventy with those over seventy years of age. Barnes R; Hadley H; Axford P; Kronholm S Urology; 1979 Oct; 14(4):359-62. PubMed ID: 494464 [No Abstract] [Full Text] [Related]
53. [Organ-specific chemotherapy of carcinoma of the prostate]. BUDNIOK R; STOLL HG; ALTVATER G Dtsch Med Wochenschr; 1955 Jan; 80(4):143-6. PubMed ID: 14352775 [No Abstract] [Full Text] [Related]
54. [Conservative treatment of carcinoma of the prostate with organ-specific chemotherapy]. SCHAFER W Dtsch Med Wochenschr; 1954 Feb; 79(6):221-3. PubMed ID: 13150842 [No Abstract] [Full Text] [Related]
55. Giant carcinoma of the prostate: angiographic demonstration of hormonally induced remission. Chait A; Stoane L; McDonald HP Br J Radiol; 1966 Nov; 39(467):876-7. PubMed ID: 5924240 [No Abstract] [Full Text] [Related]
56. A 45-year-old with neuroendocrine carcinoma of the prostate. Reichard C; Gilligan T; Watts KE; Magi-Galluzzi C; Klein EA Urology; 2013 Apr; 81(4):714-6. PubMed ID: 23414690 [No Abstract] [Full Text] [Related]
57. Planned cytostatic therapy of carcinoma of the prostate. WARNECKE CE Bruns Beitr Klin Chir; 1955 May; 190(3):341-8. PubMed ID: 14389781 [No Abstract] [Full Text] [Related]
58. [Results of conservative therapy in prostate carcinoma]. PAGEL W Z Urol; 1957; 50(12):681-8. PubMed ID: 13531567 [No Abstract] [Full Text] [Related]
59. [Controversies in the diagnosis and treatment of cancer of the prostate. Meeting of the Uro-oncologic Group of the Spanish Association of Urology. Vigo]. Nogueira-March JL; Rioja Sanz LA; Jimenez Cruz F; Martinez PiƱeiro JA; Leiva Galvis O; Resel Estevez L; Villavicencio Mavrich H; Cimadevila Covelo A; Gonzalez Martin M; Garcia Perez M Actas Urol Esp; 1992 Apr; 16(4):284-91. PubMed ID: 1636450 [No Abstract] [Full Text] [Related]
60. [Exfoliative cytology of carcinoma of the prostate: use of a specially designed prostatic fluid obtaining catheter]. Ichijo S; Nagasawa M; Katayose K; Koguchi M; Suzuki T; Shiraiwa Y Nihon Hinyokika Gakkai Zasshi; 1984 Aug; 75(8):1299-305. PubMed ID: 6513229 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]